Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
Qbox is a cloud-based, search database for businesses. Formerly known as StackSearch, it won the ARK Challenge accelerator in 2012. The funding round was led by Vulcan Ventures and other funds based in Silicon Valley.
Semiconductor manufacturer Cree Inc. has rebranded its power and radio frequency division, which includes the former Arkansas Power Electronics International of Fayetteville, as Wolfspeed, the publicly traded company announced.
Promoting startups owned by women, minorities and military veterans is the aim of the 2.7.0 accelerator from Fayetteville's Startup Junkie that began its 14-week run on Tuesday.
Cree Inc., the LED and semiconductor manufacturer that purchased Arkansas Power Electronics International of Fayetteville in July, received a $4.1 million contract from the U.S. Air Force.